{"disease":{"id":"cmv","name":"cmv"},"drugs":{"marketed":[{"drug_id":"foscarnet","indication_name":"CMV Retinitis in AIDS Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foscavir","generic_name":"FOSCARNET","company_name":"Clinigen Hlthcare","drug_phase":"marketed","molecular_target":"","drug_class":"Pyrophosphate Analog DNA Polymerase Inhibitor","quality_score":75,"revenue":null,"mechanism":"Foscarnet works by directly inhibiting viral DNA polymerase, preventing the replication of viral DNA."},{"drug_id":"foscarnet","indication_name":"CMV Retinitis Relapse","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foscavir","generic_name":"FOSCARNET","company_name":"Clinigen Hlthcare","drug_phase":"marketed","molecular_target":"","drug_class":"Pyrophosphate Analog DNA Polymerase Inhibitor","quality_score":75,"revenue":null,"mechanism":"Foscarnet works by directly inhibiting viral DNA polymerase, preventing the replication of viral DNA."},{"drug_id":"cytotec","indication_name":"Prevention of CMV Disease After Organ Transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytotec","generic_name":"Misoprostol","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors","drug_class":"NSAID combined with prostaglandin analog","quality_score":70,"revenue":null,"mechanism":"Diclofenac inhibits COX-1/COX-2 to reduce prostaglandins; misoprostol is PGE1 analog protecting gastric mucosa."},{"drug_id":"valganciclovir","indication_name":"CMV Retinitis in AIDS Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"valganciclovir","indication_name":"Prevention of CMV Disease After Cardiac Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"valganciclovir","indication_name":"Prevention of CMV Disease After Kidney Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"valganciclovir","indication_name":"Prevention of CMV Disease After Kidney-Pancreas Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valcyte","generic_name":"VALGANCICLOVIR","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":70,"revenue":null,"mechanism":"Valcyte works by inhibiting the replication of cytomegalovirus DNA through its action as a nucleoside analog DNA polymerase inhibitor."},{"drug_id":"cidofovir","indication_name":"CMV Retinitis in AIDS Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vistide","generic_name":"CIDOFOVIR","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"","drug_class":"cidofovir","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"ganciclovir","indication_name":"CMV Retinitis in AIDS Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"ganciclovir","indication_name":"CMV Retinitis in Immunocompromised Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease After Cardiac Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease After Kidney Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease After Kidney-Pancreas Transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease After Organ Transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"ganciclovir","indication_name":"Prevention of CMV Disease in Advanced HIV Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"foscarnet","indication_name":"CMV Retinitis in AIDS Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foscavir","generic_name":"FOSCARNET","company_name":"Clinigen Hlthcare","drug_phase":"marketed","molecular_target":"","drug_class":"Pyrophosphate Analog DNA Polymerase Inhibitor","quality_score":75,"revenue":null,"mechanism":"Foscarnet works by directly inhibiting viral DNA polymerase, preventing the replication of viral DNA."},{"drug_id":"dexrazoxane","indication_name":"Prevention of CMV Disease After Organ Transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zinecard","generic_name":"DEXRAZOXANE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"DNA topoisomerase 2-alpha","drug_class":"Cytoprotective Agent","quality_score":10,"revenue":null,"mechanism":"Zinecard works by binding to metal ions and preventing them from causing damage to DNA during anthracycline treatment."},{"drug_id":"misoprostol","indication_name":"Prevention of CMV Disease After Organ Transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytotec","generic_name":"misoprostol","company_name":"Generic (originally Searle/Pfizer)","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP2 subtype, Prostaglandin E2 receptor EP3 subtype, Prostaglandin E2 receptor EP4 subtype","drug_class":"Prostaglandin E1 analog","quality_score":null,"revenue":null,"mechanism":"Synthetic prostaglandin E1 analog that protects gastric mucosa by inhibiting acid secretion and stimulating mucus/bicarbonate, also causes uterine contraction."},{"drug_id":"vistide","indication_name":"CMV Retinitis in AIDS Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Vistide","company_name":"Gustave Roussy, Cancer Campus, Grand Paris","drug_phase":"marketed","molecular_target":"DNA polymerase catalytic subunit","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zinecard","indication_name":"Prevention of CMV Disease After Organ Transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zinecard","company_name":"M.D. Anderson Cancer Center","drug_phase":"phase_1","molecular_target":"DNA topoisomerase 2-beta, DNA topoisomerase 2-alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":20,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03486834","title":"V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2200,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03251261","title":"Detection of Cytomegalovirus Virus in Neonates","phase":"","overall_status":"COMPLETED","enrollment_count":1615,"lead_sponsor_name":"Meridian Bioscience, Inc.","has_results":false},{"nct_id":"NCT07443501","title":"Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1114,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06226558","title":"Long-Term Outcomes of Children With Congenital CMV in New York State","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Stony Brook University","has_results":false},{"nct_id":"NCT07393594","title":"ID-ENTITY Trial- Evaluating Serial T-ID Monitoring","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Transplant Genomics, Inc.","has_results":false},{"nct_id":"NCT03889028","title":"Pre-engraftment Cytomegalovirus DNAemia","phase":"","overall_status":"COMPLETED","enrollment_count":878,"lead_sponsor_name":"Fundación para la Investigación del Hospital Clínico de Valencia","has_results":true},{"nct_id":"NCT05958186","title":"A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Lin Zhong","has_results":true},{"nct_id":"NCT06374511","title":"Prospective Cohort Study of Complications and Outcomes in Cirrhosis","phase":"","overall_status":"RECRUITING","enrollment_count":660,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03443869","title":"Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":601,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01011712","title":"The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02137772","title":"Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02927067","title":"A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":553,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT01877655","title":"A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT06263218","title":"Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Hospital do Rim e Hipertensão","has_results":false},{"nct_id":"NCT04280380","title":"Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Fundación de investigación HM","has_results":false},{"nct_id":"NCT06798909","title":"Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02931539","title":"Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":352,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06568055","title":"A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom","phase":"","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06812598","title":"Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT","phase":"NA","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05315882","title":"Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","has_results":false},{"nct_id":"NCT07286461","title":"VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":290,"lead_sponsor_name":"University of Rome Tor Vergata","has_results":false},{"nct_id":"NCT06615921","title":"A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection","phase":"","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06577363","title":"A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05789615","title":"Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT06793124","title":"Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOweL Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT05855889","title":"Observational Study of the Management of Infants With Congenital CMV","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"St George's, University of London","has_results":false},{"nct_id":"NCT03443791","title":"Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT04278547","title":"Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":188,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false},{"nct_id":"NCT03858907","title":"Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV","phase":"","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06555432","title":"A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea","phase":"","overall_status":"RECRUITING","enrollment_count":168,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05419206","title":"The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Ramazan Gozukucuk","has_results":false},{"nct_id":"NCT03924219","title":"CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04021628","title":"Cytomegalovirus Shedding Characteristics in Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"St George's, University of London","has_results":true},{"nct_id":"NCT05576805","title":"A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06362720","title":"The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":158,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT06306989","title":"Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Cao Weijie","has_results":false},{"nct_id":"NCT07450365","title":"Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Hu Bofei","has_results":false},{"nct_id":"NCT07079735","title":"Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT01974206","title":"A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT07419204","title":"Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy","phase":"","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"Gazi University","has_results":false},{"nct_id":"NCT05522283","title":"Stool and Serum CMV-PCR in Diagnosing CMV Colitis","phase":"","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT07379203","title":"ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":130,"lead_sponsor_name":"Wits Health Consortium (Pty) Ltd","has_results":false},{"nct_id":"NCT01611974","title":"Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT05571137","title":"A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participants in Europe and Canada","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT07513623","title":"Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":117,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04017962","title":"A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT06971913","title":"Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03159364","title":"Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT07477925","title":"Immunological and Virological Prognostic Markers of Human Cytomegalovirus (HCMV) Congenital Infection in Pregnant Women With Primary HCMV Infection.","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT05432778","title":"Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}